Markets:

Overview

News

Currencies

International

Treasuries

COMPASS Pathways Plc - American Depository Shares (NQ:CMPS)

5.355 -0.055 (-1.02%)

Streaming Delayed Price Updated: 2:52 PM EDT, Mar 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about COMPASS Pathways Plc - American Depository Shares

< Previous 1 2 3 4 5 6 7 8 9

...

31 32 Next >

Compass Pathways Announces Publication of Results from Phase 2 Study of COMP360 Psilocybin for Post-Traumatic Stress Disorder

September 02, 2025

From Compass Pathfinder Limited

Via Business Wire

Compass Pathways to Participate in Four Investor Conferences in September

August 27, 2025

From Compass Pathfinder Limited

Via Business Wire

Compass Pathways to Participate in Canaccord Genuity 45th Annual Growth Conference on August 12, 2025 in Boston, MA

August 05, 2025

From Compass Pathfinder Limited

Via Business Wire

Earnings Scheduled For July 31, 2025 ↗

July 31, 2025

Via Benzinga

Compass (CMPS) Q2 Loss Improves 27% ↗

August 01, 2025

Via The Motley Fool

Compass Pathways Announces Second Quarter 2025 Financial Results and Business Highlights

July 31, 2025

From Compass Pathfinder

Via Business Wire

Compass Pathways Appoints Justin Gover to Board of Directors

July 29, 2025

From Compass Pathfinder Limited

Via Business Wire

Compass Pathways to Announce Second Quarter Financial Results on July 31, 2025

July 22, 2025

From Compass Pathfinder Limited

Via Business Wire

These 2 Stocks Could More Than Double Your Money, According to Wall Street. Is It Time to Buy? ↗

July 20, 2025

Via The Motley Fool

Compass Pathways to Participate in HC Wainwright @Home Series Interview on July 14th, 8:00am ET

July 10, 2025

From Compass Pathfinder Limited

Via Business Wire

Global Neuro-Psychiatric Disorders & Treatment Market Projected to Reach $166 Billion by 2032

July 01, 2025

From FN Media Group LLC

Via GlobeNewswire

Stifel Says Compass Pathways Selloff 'Significantly Overdone' After Psilocybin Trial Data ↗

June 24, 2025

The company is also conducting a second Phase 3 study evaluating the effects of two doses of COMP360 given three weeks apart.

Via Stocktwits

Global Neuro-Psychiatric Disorders & Treatment Market Projected to Reach $166 Billion by 2032

July 01, 2025

EQNX::TICKER_START (NYSE:CYBN),(NEO:CYBN),(NASDAQ:CMPS),(NASDAQ:SAGE),(NASDAQ:MNMD),(NASDAQ:ATAI),(NEO:MMED) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Death

What's going on in today's session ↗

June 23, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

Compass Pathways Stock Is Plunging Today: What's Going On? ↗

June 23, 2025

COMPASS Pathways Plc (NASDAQ:CMPS) stock is trading lower on Monday. The company announced it reached its primary endpoint in the ongoing Phase 3 COMP005 trial, but results may have not met lofty...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

June 23, 2025

Via Benzinga

Compass Pathways Stock Slumps After Positive Late-Stage Trial Results From Psychedelic Drug ‘Underwhelm’ Analysts ↗

June 23, 2025

The company said it will discuss the “highly statistically significant and clinically meaningful” data with the U.S. Food and Drug Administration, which has yet to review it.

Via Stocktwits

Crude Oil Falls 1%; US Services PMI Declines In June ↗

June 23, 2025

Via Benzinga

Which stocks are experiencing notable movement on Monday? ↗

June 23, 2025

Stay up-to-date with the latest market trends in the middle of the day on Monday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

Why Is Compass Pathways Stock Trading Lower On Monday? ↗

June 23, 2025

Compass Pathways' COMP005 trial met its primary endpoint in TRD, but modest results sparked a 47% drop in shares amid investor disappointment

Via Benzinga

Dow Jumps Over 200 Points; FactSet Research Shares Gain After Q3 Results ↗

June 23, 2025

Via Benzinga

Topics Stocks

These stocks are gapping in today's session ↗

June 23, 2025

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Monday.

Via Chartmill

These stocks are moving in today's pre-market session ↗

June 23, 2025

Discover the top movers in Monday's pre-market session and stay informed about market dynamics.

Via Chartmill

Vizsla Silver, COMPASS Pathways And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

June 23, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

June 23, 2025

Via Benzinga

Why Sequans Communications Shares Are Trading Higher By Over 42%; Here Are 20 Stocks Moving Premarket ↗

June 23, 2025

Via Benzinga

Compass Pathways Successfully Achieves Primary Endpoint in First Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression

June 23, 2025

From Compass Pathfinder Limited

Via Business Wire

Adobe, FibroGen And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

June 13, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

June 12, 2025

Via Benzinga

Ex-Gov't Foe Joins Trump, RFK Jr.'s HHS To Lead Psychedelics Policy: What It Means For Investors ↗

May 24, 2025

Psychedelics litigator Matthew Zorn joins HHS under RFK Jr. to lead policy. What it means for CMPS, MNMD, CYBN, PSIL & more.

Via Benzinga

Topics Government

< Previous 1 2 3 4 5 6 7 8 9

...

31 32 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.